Diana Cherkiss
Medical · Miramar, FLNPI 1013166396
Payments from drug & device makers
Across 156 payments — averaging $16.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$775
- Novo Nordisk$408
- AbbVie$257
- Lilly USA, LLC$190
- Exact Sciences$146
- AstraZeneca$136
- plus $734 from 21 others
What the payments were for
- Food & beverage$2,645100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 51 | $775 |
| Novo Nordisk | 25 | $408 |
| AbbVie | 17 | $257 |
| Lilly USA, LLC | 11 | $190 |
| Exact Sciences | 6 | $146 |
| AstraZeneca | 7 | $136 |
| Sanofi-aventis U.S. LLC | 5 | $93 |
| Amarin Pharma, Inc. | 4 | $68 |
| Pfizer | 4 | $66 |
| Amneal Pharmaceuticals LLC | 3 | $63 |
| Corcept Therapeutics | 2 | $53 |
| GSK | 2 | $42 |
| Verity Pharmaceuticals Inc. | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 2 | $32 |
| Abbott | 2 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Ardelyx, Inc. | 1 | $24 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Amgen | 1 | $21 |
| IBSA Pharma Inc. | 1 | $20 |
| Shield Therapeutics Inc | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Tolmar, Inc. | 1 | $15 |
How this compares
$2,645 in reported general payments places this provider in the 75th percentile of 2,031 medical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 12 | $6,698 |
| Liothyronine Sodium | 14 | $695 |
| Donepezil Hcl | 12 | $410 |
| Atorvastatin Calcium | 37 | $281 |
| Metformin Hcl | 18 | $196 |
| Duloxetine Hcl | 16 | $182 |
| Amlodipine Besylate | 33 | $176 |
| Rosuvastatin Calcium | 19 | $144 |
| Lisinopril | 20 | $104 |
| Pantoprazole Sodium | 15 | $83 |
| Ezetimibe | 12 | $61 |
| Montelukast Sodium | 14 | $50 |
| Hydrochlorothiazide | 11 | $46 |
| Anastrozole | 11 | $40 |
| Carvedilol | 12 | $32 |
Paid to pharmacies, not to this prescriber.
Other medical in Miramar
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
- Francine PhillipsLand O Lakes$145K
- Chelsie FerrellDeland$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.